Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan, China, in 2019. It is the causal agent
Read moreHome ยป
Coronavirus Disease
SARS-CoV-2 vaccine efficacy is strongly correlated with antibody neutralization levels
All COVID-19 vaccines appear less effective when faced with variants such as Delta, according to a new medRxiv* study. However,
Read moreStudy suggests children develop short-term humoral immunity following SARS-CoV-2 infection
A single-center, cross-sectional epidemiological survey conducted in Israel has recently pointed out that antibodies induced by natural severe acute respiratory
Read moreSARS-CoV-2 mRNA vaccine efficacy reduced in patients with CD20-B-cell depleting treatment history
Studies have shown that age and male sex are the key drivers for severe COVID-19, apart from other factors such
Read morealprazolam arret brutal
Younger patients, including adolescents, are less likely to suffer severe coronavirus disease 2019 (COVID-19) symptoms. This is the case even
Read moreamoxicillin plus clavulanic acid and alcohol
Natural compounds have become a popular source of interest for drug development due to some successes in their employment against
Read moreprednisone topical over the counter
Several studies have reported that coronavirus disease 2019 (COVID-19) appears to leave a prolonged mark on those affected by it.
Read moreFDA approves investigational monoclonal antibody therapy sotrovimab for COVID-19
The U.S. Food and Drug Administration (FDA) has given the green light on the investigational monoclonal antibody therapy, sotrovimab, as
Read moreResearchers design compounds that prevent SARS-CoV-2 entry in human lung cells
Researchers have designed a new class of TMPRSS2 inhibitors that have shown broad antiviral activity against coronaviruses, including the severe
Read more